相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry
A. G. Dinmohamed et al.
LEUKEMIA (2015)
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry
T. Bernal et al.
LEUKEMIA (2015)
Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study
David Valcarcel et al.
LANCET HAEMATOLOGY (2015)
Clustering of comorbidides is related to age and sex and impacts clinical outcome in myelodysplastic syndromes
Christoph Bammer et al.
JOURNAL OF GERIATRIC ONCOLOGY (2014)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
Rafael Bejar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study
Malin Hultcrantz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome
Matteo G. Della Porta et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients
Massimo Breccia et al.
LEUKEMIA RESEARCH (2011)
Incidence and Clinical Complications of Myelodysplastic Syndromes Among United States Medicare Beneficiaries
Stuart L. Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005
Asa Rangert Derolf et al.
BLOOD (2009)
The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome
Esther Zipperer et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Mechanisms of Disease: Myelodysplastic Syndromes.
Ayalew Tefferi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The changing prevalence of comorbidity across the age spectrum
Jay F. Piccirillo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
How to interpret the relative survival ratios of cancer patients
Arun Pokhrel et al.
EUROPEAN JOURNAL OF CANCER (2008)
A prognostic score for patients with lower risk myelodysplastic syndrome
G. Garcia-Manero et al.
LEUKEMIA (2008)
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making
L Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Regression models for relative survival
PW Dickman et al.
STATISTICS IN MEDICINE (2004)
分享论文
